Cargando…

Response to: A myth of ophthalmic beta-blockers therapy

Detalles Bibliográficos
Autor principal:	Wolfs, Roger C. W.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2009
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776154/ https://www.ncbi.nlm.nih.gov/pubmed/19693528 http://dx.doi.org/10.1007/s00417-009-1163-x

Ejemplares similares

Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy
por: Lee, Heirim, et al.
Publicado: (2022)

Beta-blocker Rebound Phenomenon in an Adolescent with Graves’ Disease
por: Anık, Ahmet
Publicado: (2022)

Atrioventricular block after reperfusion: A reflection on early beta-blocker therapy for acute myocardial infarction
por: Zhong, Yue, et al.
Publicado: (2017)

Dangers in using beta-blockers in patients with venovenous extracorporeal membrane oxygenation
por: Álvarez, Diego Rodríguez, et al.
Publicado: (2022)

Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker?
por: Guo, Yong-Fang, et al.
Publicado: (2011)

Comment on ‘Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma'
por: Ji, Y, et al.
Publicado: (2013)

Is the use of non-selective beta-blockers necessary in cirrhotic patients with small varices?
por: Qi, Xingshun, et al.
Publicado: (2014)

Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure
por: Liu, Baoshan, et al.
Publicado: (2023)

Response to “Letter To Editor: Internet addiction disorder: Hype, a myth”
por: Dalal, P. K., et al.
Publicado: (2016)

Disease-modifying medications in heart failure: more than ACE inhibitors and beta blockers
por: Chao, Chia-Ter
Publicado: (2011)

Morgellons disease: A myth or reality?
por: Ranka, Nishita, et al.
Publicado: (2016)

Shockwave Therapy for the Prevention of Paradoxical Adipose Hyperplasia After Cryolipolysis: Myth or Reality?
por: Michon, Alain
Publicado: (2021)

Pathway to psychiatric care and cultural myth
por: Chowdhury, Arabinda N.
Publicado: (2012)

Posterior ectopic anus: Myth or reality?
por: Pandey, Anand, et al.
Publicado: (2015)

Drug expiry debate: the myth and the reality
por: Gikonyo, Dan, et al.
Publicado: (2019)

Internet addiction disorder: Hype, a myth
por: Bipeta, Rajshekhar
Publicado: (2016)

A Review on Ophthalmic Manifestations of Brucellosis and Reporting a Case of Ophthalmic Brucellosis
por: Ghasemi Barghi, R, et al.
Publicado: (2011)

Reply: Comment on ‘Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma' – β-blockers are potent anti-angiogenic and chemo-sensitising agents, rather than cytotoxic drugs
por: Pasquier, E, et al.
Publicado: (2013)

Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic?
por: de Roquetaillade, Charles, et al.
Publicado: (2022)

Tips in ophthalmic photography
por: Kamath, Sripathi B, et al.
Publicado: (2012)

Anti-oxidative trypanocidal drugs, myth or reality
por: Saeidnia, Soodabeh
Publicado: (2013)

Not too quick on “Debunking the myth of ‘Blue Mondays’”
por: Flameling, Jacob, et al.
Publicado: (2022)

Evaluation of risk of falls and orthostatic hypotension in older, long-term topical beta-blocker users
por: Ramdas, Wishal D., et al.
Publicado: (2009)

Spontaneous recovery in Autistic Spectrum Disorders ‐ A myth?
por: Helal, M. N., et al.
Publicado: (2010)

Improving quality control for in‐clinic hematology analyzers: Common myths and opportunities
por: Michael, Helen T., et al.
Publicado: (2022)

SARS-CoV-2 and the myths about vaccination()
por: Travezaño-Cabrera, Aaron, et al.
Publicado: (2021)

Busting the myth: waste-to-energy plants and public health
por: Traven, Luka
Publicado: (2023)

Postgraduate ophthalmic education in India?
por: Parikh, Rajul S
Publicado: (2009)

Functional barriers to acceptance of the WHO Surgical Safety Checklist are just myths!
por: Kapoor, Mukul C.
Publicado: (2018)

Personalised Medicine with IL-23 Blockers: Myth or Reality?
por: Gottlieb, Zoë S, et al.
Publicado: (2021)

Envisaging a trans-fat free India? - A myth or reality
por: Saleem, Sheikh Mohd, et al.
Publicado: (2021)

Isolated left ventricular non-compaction in Africa: elucidating myths
por: Peters, Ferande, et al.
Publicado: (2013)

Parasites Protect from Severe COVID-19. Myth or Reality?
por: Makram, Abdelrahman M, et al.
Publicado: (2022)

Response to comments on: Neuro-ophthalmic presentation of COVID-19 disease: A case report
por: Katti, Venkatram, et al.
Publicado: (2021)

Ophthalmic Disorders in Adult Lymphoma Patients
por: Javed Ali, Mohammad, et al.
Publicado: (2010)

Ophthalmic biosimilars: Lessons from India
por: Sharma, Ashish, et al.
Publicado: (2019)

Managing media during ophthalmic crisis
por: Bhatia, Ragini, et al.
Publicado: (2020)

Ophthalmic complications of COVID-19 vaccination
por: Pawar, Neelam, et al.
Publicado: (2021)

A comparison of hypotension and bradycardia following spinal anaesthesia in patients on calcium channel blockers and β-blockers
por: Patil, Amol, et al.
Publicado: (2013)

Response to Abdelrahman M et al commentary on “Parasites Protect from Severe COVID-19. Myth or Reality?”
por: Wolday, Dawit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f2gv3q6gs52b37aluf65mcr6i8